Now appearing in operating theaters: Google Glass

Christopher Kaeding adjusts Google Glass before operating
Christopher Kaeding adjusts Google Glass before operating

In addition to donning scrubs before entering the OR, several surgeons have slipped on Google Glass, the augmented-reality enabling goggles.

One general/trauma surgeon, who blogs at rgrosssz.wordpress.com, described using Glass while inserting a patient's PEG tube. Images, sans the patient's face, were beamed to an iPad. “I was able to show not just the patient's abdomen, but also the endoscopic view, in a very clever, simple and inexpensive way,” he wrote.

A cardiothoracic surgeon at UCSF Medical Center used Glass to compare a patient's CAT scan images with what he was seeing in front of him. “He likened the experience to driving a car and glancing in the rearview mirror,” reported Fast Company's Fast CoExist blog, based on the doctor's talk at Rock Health's Health Innovation Summit.

Surgeons at The Ohio State University Wexner Medical Center crowed about an ACL repair that they transmitted live.

“Once we got into the surgery, I often forgot the device was there,” said the surgeon, Dr. Christopher Kaeding, as reported by the university.

“We're very excited about the opportunities this device could provide for education,” said Wexner's chief innovation officer, Dr. Clay Marsh. “Beyond that, it could be a game-changer for the doctor during the surgery itself.”
You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.